Display options
Cite
Baum E, Peters KM. The diagnosis and treatment of primary osteoporosis according to current guidelines. Dtsch Arztebl Int. 2008;105(33):573-81; quiz 581-2doi: 10.3238/arztebl.2008.0573.
Baum, E., & Peters, K. M. (2008). The diagnosis and treatment of primary osteoporosis according to current guidelines. Deutsches Arzteblatt international, 105(33), 573-81; quiz 581-2. https://doi.org/10.3238/arztebl.2008.0573
Baum, Erika, and Peters, Klaus M. "The diagnosis and treatment of primary osteoporosis according to current guidelines." Deutsches Arzteblatt international vol. 105,33 (2008): 573-81; quiz 581-2. doi: https://doi.org/10.3238/arztebl.2008.0573
Baum E, Peters KM. The diagnosis and treatment of primary osteoporosis according to current guidelines. Dtsch Arztebl Int. 2008 Aug;105(33):573-81; quiz 581-2. doi: 10.3238/arztebl.2008.0573. Epub 2008 Aug 15. PMID: 19471676; PMCID: PMC2680556.
Copy Download .nbib Format: NLM
Share it on

Dtsch Arztebl Int. 2008 Aug;105(33):573-81; quiz 581-2. doi: 10.3238/arztebl.2008.0573. Epub 2008 Aug 15.

The diagnosis and treatment of primary osteoporosis according to current guidelines.

Deutsches Arzteblatt international

Erika Baum, Klaus M Peters

Affiliations

  1. Abteilung für Allgemeinmedizin, präventive und rehabilitative Medizin, Universität Marburg sowie Hausarztpraxis in Biebertal.

PMID: 19471676 PMCID: PMC2680556 DOI: 10.3238/arztebl.2008.0573

Abstract

INTRODUCTION: Osteoporosis is the most common generalized disease of the skeleton, yet it is markedly undertreated in Germany.

METHODS: Selective literature review on the basis of the current German guidelines regarding the prevention, diagnosis, and treatment of osteoporosis in postmenopausal women and in men aged 60 and above, and a further search of literature published in the last three years.

RESULTS AND DISCUSSION: The indication for dual X-ray absorptiometry (DXA) measurement for the specific diagnosis of osteoporosis is derived from the patient's age, sex, history of fractures in the past, and further risk factors. The therapeutic threshold for osteoporosis has been set at a 30% predicted risk of osteoporotic fractures occurring within 10 years. The treatment consists of basic measures for fracture prevention combined with specific pharmacotherapy. The recommended drugs for the treatment of osteoporosis in postmenopausal women in particular are alendronic and ibandronic acid, raloxifen, risedronic acid, and strontium ranelate; the only approved drugs for men at present are alendronic and risedronic acid and teriparatid. Intensive patient education markedly improves the otherwise poor compliance with osteoporosis treatment.

Keywords: compliance; diagnosis; guidelines; osteoporosis; therapeutic threshold

References

  1. J Am Geriatr Soc. 2005 Oct;53(10):1697-704 - PubMed
  2. JAMA. 2007 Nov 28;298(20):2381-8 - PubMed
  3. J Am Geriatr Soc. 2006 Mar;54(3):450-7 - PubMed
  4. Osteoporos Int. 2006;17(9):1309-17 - PubMed
  5. Int J Oral Maxillofac Implants. 2006 May-Jun;21(3):349-53 - PubMed
  6. Med Care. 2005 Mar;43(3):293-302 - PubMed
  7. Isr Med Assoc J. 2003 Dec;5(12):859-62 - PubMed
  8. J Bone Joint Surg Am. 2005 Jan;87(1):3-7 - PubMed
  9. Nihon Rinsho. 2006 Sep;64(9):1687-91 - PubMed
  10. Arch Intern Med. 2007 Jan 22;167(2):155-60 - PubMed
  11. J Gen Intern Med. 2007 Mar;22(3):362-7 - PubMed
  12. JAMA. 2006 Dec 27;296(24):2927-38 - PubMed
  13. Osteoporos Int. 2007 Jan;18(1):45-57 - PubMed
  14. Arch Intern Med. 2006 Apr 24;166(8):869-75 - PubMed
  15. Lancet. 2007 Aug 25;370(9588):657-66 - PubMed
  16. Am J Med. 2007 Oct;120(10):886-92 - PubMed
  17. Osteoporos Int. 2005 Jan;16(1):71-7 - PubMed
  18. Ned Tijdschr Geneeskd. 2007 Jun 30;151(26):1445-8 - PubMed

Publication Types